Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:
“Amcenestrant Plus Palbociclib vs Letrozole Plus Palbociclib in ER–Positive, HER 2–Negative Advanced BC: Primary Results From AMEERA-5
PFS-HR:1.2
This study was discontinued on the recommendation of the data monitoring committee.”
Read further.
Source: Yakup Ergün/X